Home/Filings/4/0001209191-21-018632
4//SEC Filing

Buck Jill 4

Accession 0001209191-21-018632

CIK 0001107421other

Filed

Mar 7, 7:00 PM ET

Accepted

Mar 8, 5:30 PM ET

Size

7.2 KB

Accession

0001209191-21-018632

Insider Transaction Report

Form 4
Period: 2021-03-04
Buck Jill
EVP, GM Gene Therapy
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-03-04+236,250236,250 total
    Exercise: $4.31Exp: 2031-03-04Common Stock (236,250 underlying)
  • Award

    Common Stock

    2021-03-04+31,500231,016 total
Footnotes (2)
  • [F1]7,875 shares shall vest on each of 12/31/2021, 12/31/2022, 12/31/2023 and 12/31/2024.
  • [F2]1/16th of the shares underlying this option will vest in equal quarterly installments commencing one quarterly period after 12/31/2020.

Issuer

ZIOPHARM ONCOLOGY INC

CIK 0001107421

Entity typeother

Related Parties

1
  • filerCIK 0001780426

Filing Metadata

Form type
4
Filed
Mar 7, 7:00 PM ET
Accepted
Mar 8, 5:30 PM ET
Size
7.2 KB